Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun;10(2):e40.
doi: 10.1002/ctm2.40. Epub 2020 Jun 4.

Clinical characteristics and risk factors for mortality among inpatients with COVID-19 in Wuhan, China

Fuyang Chen  1 , Wenwu Sun  1 , Shengrong Sun  2 , Zhiyu Li  2 , Zhong Wang  2 , Li Yu  1
Affiliations

Clinical characteristics and risk factors for mortality among inpatients with COVID-19 in Wuhan, China

Fuyang Chen et al. Clin Transl Med. 2020 Jun.
No abstract available

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Temporal changes in laboratory markers and the death risk factors of COVID‐19. A, Association of risk factors of COVID‐19. B and C, Temporal changes in lactate dehydrogenase, creatine kinase‐MB (CKMB), creatinine, neutrophil count, blood urea nitrogen, alanine aminotransferase, d‐dimer, CRP, procalcitonin, white blood cell count, lymphocyte count, and eosinophilic granulocyte. D and E, Cumulative incidence for inpatients with COVID‐19 sub‐grouped by chronic obstructive pulmonary disease, hypertension, myocardial infarction, cerebral infarction, lymphocyte, CD4+ T cell, CD8+ T cell, and C‐reactive protein
See this image and copyright information in PMC

References

    1. WHO . Coronavirus disease (COVID‐19) outbreak situation by WHO. https://www.who.int/emergencies/diseases/novel-coronavirus-2019
    1. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID‐19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054‐1062. - PMC - PubMed
    1. Menezes KK, Nascimento LR, Avelino PR, Alvarenga MTM, Teixeira‐Salmela LF. Efficacy of interventions to improve respiratory function after stroke. Respir Care. 2018;63(7):920‐933. - PubMed
    1. Levine SR. Hypercoagulable states and stroke: a selective review. CNS Spectr. 2005;10(7):567‐578. - PubMed
    1. Abassi ZA, Skorecki K, Heyman SN, Kinaneh S, Armaly Z. Covid‐19 infection and mortality—a physiologist's perspective enlightening clinical features and plausible interventional strategies. Am J Physiol Lung Cell Mol Physiol. 2020. 10.1152/ajplung.00097.2020 - DOI - PMC - PubMed

LinkOut - more resources